Keyphrases
Ribavirin
100%
Zika Virus
100%
Favipiravir
100%
In Vitro Susceptibility
100%
Plaque Reduction Assay
66%
T-705
66%
Zika
66%
Infected Individual
33%
Synergistic Effect
33%
Inhibitory Activity
33%
Comorbidity
33%
Antiretroviral Therapy
33%
IC50 Value
33%
In Vitro Activity
33%
Mosquito-borne Viruses
33%
IC50
33%
Congenital Disorders
33%
Myelitis
33%
Guillain-Barré Syndrome
33%
50% Inhibitory Concentration
33%
Meningoencephalitis
33%
RNA Polymerase Inhibitor
33%
Phenotypic Methods
33%
Complicated Disease
33%
Medicine and Dentistry
In Vitro
100%
Ribavirin
100%
Zika Virus
100%
Favipiravir
100%
IC50
75%
Disease
25%
Antiviral Therapy
25%
Congenital Disorder
25%
Meningoencephalitis
25%
RNA Polymerase
25%
Transverse Myelitis
25%
Comorbidity
25%
Mosquito-Borne Virus
25%
Pharmacology, Toxicology and Pharmaceutical Science
Ribavirin
100%
IC50
100%
Zika Virus
100%
Favipiravir
100%
Disease
33%
Syndrome
33%
Antiviral Therapy
33%
RNA Polymerase
33%
Congenital Disorder
33%
Meningoencephalitis
33%
Myelitis
33%
Comorbidity
33%